Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Challenges in grading based on disease free survival


28 Sep 2019


ESMO-MCBS: What have we learnt and how can we expand?


André Ilbawi


D. Kaidarova1, A. Ilbawi2

Author affiliations

  • 1 Kazakh Reserch Institute of Oncology & Radiology, 490 078 - Almaty/KZ
  • 2 Department For Management Of Ncds, Disability, Violence And Injury Prevention, WHO - World Health Organization, 1211 - Geneva/CH


Resources from the same session

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings